IP Library Granted Patent US 8,857,430
Granted Patent B2
US 8,857,430 · App. 13/962,493 · Granted Oct 14, 2014

Ventilatory assistance for treatment of cardiac failure and cheyne-stokes breathing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,857,430
App. No.
13/962,493
Granted
Oct 14, 2014
Kind
B2
Abstract

Method and apparatus for the treatment of cardiac failure, Cheyne Stokes breathing or central sleep apnea are disclosed. A subject is provided with ventilatory support Respiratory airflow is determined. From the respiratory airflow are derived a measure of instantaneous ventilation and a measure of longterm average ventilation. A target ventilation is taken as 95% of the longterm average ventilation. The instantaneous ventilation is fed as the input signal to a clipped integral controller, with the target ventilation as the reference signal. The output of the controller determines the degree of ventilatory support. A third measure of ventilation, for example instantaneous ventilation low pass filtered with a time constant of 5 seconds, is calculated. Ventilatory support is in phase with the subject's respiratory airflow to the fuzzy extent that this ventilation is above target, and at a preset rate conversely.

Claims (24)

1. An apparatus for the treatment of cardiac failure, Cheyne-Stokes breathing or central sleep apnea, the apparatus comprising:

a controllable source of breathable gas at positive pressure;

means for delivering said breathable gas at positive pressure to a subject's airway;

means for deriving a measure of respiratory airflow of the subject; and

a servo-controller configured to accept an input variable and a reference quantity, and produce an output to bring the value of the input variable towards the value of the reference quantity;

wherein

(i) said input variable is a measure of instantaneous ventilation, and

(ii) said reference quantity is a percentage of a long-term measure of ventilation continuously derived as half the absolute value of the respiratory airflow, the long-term measure of ventilation being low-pass filtered with a time constant that is long compared with the lung-chemoreceptor delay in patients with Cheyne-Stokes breathing or central sleep apnea.

2. The apparatus of claim 1 , wherein said time constant is longer than the waxing-waning cycle time of untreated Cheyne-Stokes breathing or central sleep apnea.

3. The apparatus of claim 1 , wherein said time constant is one hundred seconds.

4. The apparatus of claim 1 wherein said percentage of said long-term measure of ventilation is smaller than a value that will result in positive feedback and larger than one that will permit residual Cheyne-Stokes breathing.

5. The apparatus of claim 4 wherein said percentage is 95%.

6. The apparatus of claim 1 wherein said measure of instantaneous ventilation is calculated as the volume of said breathable gas inspired over a period of time less than several seconds.

7. The apparatus of claim 1 wherein said measure of instantaneous ventilation is calculated as the volume of said breathable gas expired over a period of time less than several seconds.

8. The apparatus of claim 1 wherein said measure of instantaneous ventilation is calculated as the average of the volumes of said breathable gas inspired and expired over a period of time less than several seconds.

9. The apparatus of claim 1 wherein said measure of instantaneous ventilation is calculated as half the average of the absolute value of the respiratory airflow over an interval that is short compared with several seconds.

10. The apparatus of claim 1 wherein said measure of instantaneous ventilation is calculated as half the absolute value of the respiratory airflow, the measure of instantaneous ventilation being low-pass filtered with a time constant that is short compared with several seconds.

11. The apparatus of claim 1 wherein said servo-controller is further operable to clip the degree of ventilatory support provided by the breathable gas delivered to the subject's airway to prevent the degree of ventilatory support provided thereby from falling below a minimum degree of support, said minimum degree of support being sufficient to perform some of the respiratory work of the subject but being less than the ventilatory support that is required to perform all of the respiratory work of the subject.

12. The apparatus claim 1 wherein said servo-controller is further operable to clip the degree of ventilatory support provided by the breathable gas delivered to the subject's airway to prevent the degree of ventilatory support provided thereby from exceeding a maximum degree of support, said maximum degree of support being sufficient to perform most or all of the subject's work of breathing, but not being sufficient to be dangerous.

13. The apparatus of claim 1 wherein said servo-controller is further operable to modulate the breathable gas delivered to the subject's airway in phase with the subject's respiratory air flow when the subject is breathing adequately, and to modulate the breathable gas delivered to the subject's airway at a preset rate when the subject is not breathing adequately.

14. A method of calculating a control signal, based on an obtained measure of a subject's respiratory airflow, said signal being suitable for controlling the delivery of breathable gas at positive pressure to the subject's airway in the treatment of cardiac failure, Cheyne-Stokes breathing or central sleep apnea, said method comprising:

a servo-control procedure accepting an input variable and a reference quantity, and producing said control signal as an output of the servo-control procedure, wherein the output is suitable for bringing the value of the input variable towards the value of the reference quantity; wherein

(i) said input variable is an obtained measure of instantaneous ventilation of the subject, and

(ii) said reference quantity is a percentage of a long-term measure of ventilation continuously derived as half the absolute value of the respiratory airflow, the long-term measure of ventilation being low-pass filtered with a time constant that is long compared with the lung-chemoreceptor delay in patients with Cheyne-Stokes breathing or central sleep apnea.

Assignments (2)
CHANGE OF NAME Recorded Jun 6, 2019
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 049454/0442 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2014
From: BERTHON-JONES, MICHAEL
To: RESMED LIMITED
Reel/Frame 032428/0308 →